Global Addictions Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 934242 | Published Date: Feb 2026 | No. of Page: 106 | Base Year: 2025 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Addictions Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Alcohol Addiction Therapeutics
        1.2.3 Tobacco Addiction Therapeutics
        1.2.4 Drug Addiction Therapeutics
    1.3 Market by Application
        1.3.1 Global Addictions Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Public
        1.3.3 Private
        1.3.4 Government
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Addictions Therapeutics Market Perspective (2016-2027)
    2.2 Addictions Therapeutics Growth Trends by Regions
        2.2.1 Addictions Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Addictions Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Addictions Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Addictions Therapeutics Industry Dynamic
        2.3.1 Addictions Therapeutics Market Trends
        2.3.2 Addictions Therapeutics Market Drivers
        2.3.3 Addictions Therapeutics Market Challenges
        2.3.4 Addictions Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Addictions Therapeutics Players by Revenue
        3.1.1 Global Top Addictions Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Addictions Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Addictions Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Addictions Therapeutics Revenue
    3.4 Global Addictions Therapeutics Market Concentration Ratio
        3.4.1 Global Addictions Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Addictions Therapeutics Revenue in 2020
    3.5 Addictions Therapeutics Key Players Head office and Area Served
    3.6 Key Players Addictions Therapeutics Product Solution and Service
    3.7 Date of Enter into Addictions Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Addictions Therapeutics Breakdown Data by Type
    4.1 Global Addictions Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Addictions Therapeutics Forecasted Market Size by Type (2022-2027)

5 Addictions Therapeutics Breakdown Data by Application
    5.1 Global Addictions Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Addictions Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Addictions Therapeutics Market Size (2016-2027)
    6.2 North America Addictions Therapeutics Market Size by Type
        6.2.1 North America Addictions Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Addictions Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Addictions Therapeutics Market Size by Type (2016-2027)
    6.3 North America Addictions Therapeutics Market Size by Application
        6.3.1 North America Addictions Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Addictions Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Addictions Therapeutics Market Size by Application (2016-2027)
    6.4 North America Addictions Therapeutics Market Size by Country
        6.4.1 North America Addictions Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Addictions Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Addictions Therapeutics Market Size (2016-2027)
    7.2 Europe Addictions Therapeutics Market Size by Type
        7.2.1 Europe Addictions Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Addictions Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Addictions Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Addictions Therapeutics Market Size by Application
        7.3.1 Europe Addictions Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Addictions Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Addictions Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Addictions Therapeutics Market Size by Country
        7.4.1 Europe Addictions Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Addictions Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Addictions Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Addictions Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Addictions Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Addictions Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Addictions Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Addictions Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Addictions Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Addictions Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Addictions Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Addictions Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Addictions Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Addictions Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Addictions Therapeutics Market Size (2016-2027)
    9.2 Latin America Addictions Therapeutics Market Size by Type
        9.2.1 Latin America Addictions Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Addictions Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Addictions Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Addictions Therapeutics Market Size by Application
        9.3.1 Latin America Addictions Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Addictions Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Addictions Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Addictions Therapeutics Market Size by Country
        9.4.1 Latin America Addictions Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Addictions Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Addictions Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Addictions Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Addictions Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Addictions Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Addictions Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Addictions Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Addictions Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Addictions Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Addictions Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Addictions Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Addictions Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Addictions Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Alkermes Plc
        11.1.1 Alkermes Plc Company Details
        11.1.2 Alkermes Plc Business Overview
        11.1.3 Alkermes Plc Addictions Therapeutics Introduction
        11.1.4 Alkermes Plc Revenue in Addictions Therapeutics Business (2016-2021)
        11.1.5 Alkermes Plc Recent Development
    11.2 Amneal Pharmaceuticals Inc.
        11.2.1 Amneal Pharmaceuticals Inc. Company Details
        11.2.2 Amneal Pharmaceuticals Inc. Business Overview
        11.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Introduction
        11.2.4 Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2016-2021)
        11.2.5 Amneal Pharmaceuticals Inc. Recent Development
    11.3 Indivior Plc
        11.3.1 Indivior Plc Company Details
        11.3.2 Indivior Plc Business Overview
        11.3.3 Indivior Plc Addictions Therapeutics Introduction
        11.3.4 Indivior Plc Revenue in Addictions Therapeutics Business (2016-2021)
        11.3.5 Indivior Plc Recent Development
    11.4 Johnson & Johnson Services Inc.
        11.4.1 Johnson & Johnson Services Inc. Company Details
        11.4.2 Johnson & Johnson Services Inc. Business Overview
        11.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Introduction
        11.4.4 Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2016-2021)
        11.4.5 Johnson & Johnson Services Inc. Recent Development
    11.5 Mylan NV
        11.5.1 Mylan NV Company Details
        11.5.2 Mylan NV Business Overview
        11.5.3 Mylan NV Addictions Therapeutics Introduction
        11.5.4 Mylan NV Revenue in Addictions Therapeutics Business (2016-2021)
        11.5.5 Mylan NV Recent Development
    11.6 Novartis AG
        11.6.1 Novartis AG Company Details
        11.6.2 Novartis AG Business Overview
        11.6.3 Novartis AG Addictions Therapeutics Introduction
        11.6.4 Novartis AG Revenue in Addictions Therapeutics Business (2016-2021)
        11.6.5 Novartis AG Recent Development
    11.7 Novo Nordisk AS
        11.7.1 Novo Nordisk AS Company Details
        11.7.2 Novo Nordisk AS Business Overview
        11.7.3 Novo Nordisk AS Addictions Therapeutics Introduction
        11.7.4 Novo Nordisk AS Revenue in Addictions Therapeutics Business (2016-2021)
        11.7.5 Novo Nordisk AS Recent Development
    11.8 Opiant Pharmaceuticals Inc.
        11.8.1 Opiant Pharmaceuticals Inc. Company Details
        11.8.2 Opiant Pharmaceuticals Inc. Business Overview
        11.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Introduction
        11.8.4 Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2016-2021)
        11.8.5 Opiant Pharmaceuticals Inc. Recent Development
    11.9 Pfizer Inc.
        11.9.1 Pfizer Inc. Company Details
        11.9.2 Pfizer Inc. Business Overview
        11.9.3 Pfizer Inc. Addictions Therapeutics Introduction
        11.9.4 Pfizer Inc. Revenue in Addictions Therapeutics Business (2016-2021)
        11.9.5 Pfizer Inc. Recent Development
    11.10 Teva Pharmaceutical Industries Ltd.
        11.10.1 Teva Pharmaceutical Industries Ltd. Company Details
        11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
        11.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Introduction
        11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2016-2021)
        11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Addictions Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Alcohol Addiction Therapeutics
    Table 3. Key Players of Tobacco Addiction Therapeutics
    Table 4. Key Players of Drug Addiction Therapeutics
    Table 5. Global Addictions Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Addictions Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Addictions Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Addictions Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Addictions Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Addictions Therapeutics Market Share by Regions (2022-2027)
    Table 11. Addictions Therapeutics Market Trends
    Table 12. Addictions Therapeutics Market Drivers
    Table 13. Addictions Therapeutics Market Challenges
    Table 14. Addictions Therapeutics Market Restraints
    Table 15. Global Addictions Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Addictions Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Addictions Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addictions Therapeutics as of 2020)
    Table 18. Ranking of Global Top Addictions Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Addictions Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Addictions Therapeutics Product Solution and Service
    Table 22. Date of Enter into Addictions Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Addictions Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Addictions Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Addictions Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Addictions Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Addictions Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Addictions Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Addictions Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Addictions Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Addictions Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Addictions Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Addictions Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Addictions Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Addictions Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Addictions Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Addictions Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Addictions Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Addictions Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Addictions Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Addictions Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Addictions Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Addictions Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Alkermes Plc Company Details
    Table 63. Alkermes Plc Business Overview
    Table 64. Alkermes Plc Addictions Therapeutics Product
    Table 65. Alkermes Plc Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. Alkermes Plc Recent Development
    Table 67. Amneal Pharmaceuticals Inc. Company Details
    Table 68. Amneal Pharmaceuticals Inc. Business Overview
    Table 69. Amneal Pharmaceuticals Inc. Addictions Therapeutics Product
    Table 70. Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. Amneal Pharmaceuticals Inc. Recent Development
    Table 72. Indivior Plc Company Details
    Table 73. Indivior Plc Business Overview
    Table 74. Indivior Plc Addictions Therapeutics Product
    Table 75. Indivior Plc Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. Indivior Plc Recent Development
    Table 77. Johnson & Johnson Services Inc. Company Details
    Table 78. Johnson & Johnson Services Inc. Business Overview
    Table 79. Johnson & Johnson Services Inc. Addictions Therapeutics Product
    Table 80. Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Johnson & Johnson Services Inc. Recent Development
    Table 82. Mylan NV Company Details
    Table 83. Mylan NV Business Overview
    Table 84. Mylan NV Addictions Therapeutics Product
    Table 85. Mylan NV Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Mylan NV Recent Development
    Table 87. Novartis AG Company Details
    Table 88. Novartis AG Business Overview
    Table 89. Novartis AG Addictions Therapeutics Product
    Table 90. Novartis AG Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Novartis AG Recent Development
    Table 92. Novo Nordisk AS Company Details
    Table 93. Novo Nordisk AS Business Overview
    Table 94. Novo Nordisk AS Addictions Therapeutics Product
    Table 95. Novo Nordisk AS Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. Novo Nordisk AS Recent Development
    Table 97. Opiant Pharmaceuticals Inc. Company Details
    Table 98. Opiant Pharmaceuticals Inc. Business Overview
    Table 99. Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Opiant Pharmaceuticals Inc. Recent Development
    Table 101. Pfizer Inc. Company Details
    Table 102. Pfizer Inc. Business Overview
    Table 103. Pfizer Inc. Addictions Therapeutics Product
    Table 104. Pfizer Inc. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Pfizer Inc. Recent Development
    Table 106. Teva Pharmaceutical Industries Ltd. Company Details
    Table 107. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 108. Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Product
    Table 109. Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Addictions Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Alcohol Addiction Therapeutics Features
    Figure 3. Tobacco Addiction Therapeutics Features
    Figure 4. Drug Addiction Therapeutics Features
    Figure 5. Global Addictions Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Public Case Studies
    Figure 7. Private Case Studies
    Figure 8. Government Case Studies
    Figure 9. Addictions Therapeutics Report Years Considered
    Figure 10. Global Addictions Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Addictions Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Addictions Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 13. Global Addictions Therapeutics Market Share by Regions (2022-2027)
    Figure 14. Global Addictions Therapeutics Market Share by Players in 2020
    Figure 15. Global Top Addictions Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addictions Therapeutics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Addictions Therapeutics Revenue in 2020
    Figure 17. Global Addictions Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 18. Global Addictions Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 19. North America Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Addictions Therapeutics Market Share by Type (2016-2027)
    Figure 21. North America Addictions Therapeutics Market Share by Application (2016-2027)
    Figure 22. North America Addictions Therapeutics Market Share by Country (2016-2027)
    Figure 23. United States Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Addictions Therapeutics Market Share by Type (2016-2027)
    Figure 27. Europe Addictions Therapeutics Market Share by Application (2016-2027)
    Figure 28. Europe Addictions Therapeutics Market Share by Country (2016-2027)
    Figure 29. Germany Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Addictions Therapeutics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Addictions Therapeutics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Addictions Therapeutics Market Share by Region (2016-2027)
    Figure 39. China Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Addictions Therapeutics Market Share by Type (2016-2027)
    Figure 47. Latin America Addictions Therapeutics Market Share by Application (2016-2027)
    Figure 48. Latin America Addictions Therapeutics Market Share by Country (2016-2027)
    Figure 49. Mexico Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Addictions Therapeutics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Addictions Therapeutics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Addictions Therapeutics Market Share by Country (2016-2027)
    Figure 55. Turkey Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Addictions Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Alkermes Plc Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 59. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 60. Indivior Plc Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 61. Johnson & Johnson Services Inc. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 62. Mylan NV Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 63. Novartis AG Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 64. Novo Nordisk AS Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 65. Opiant Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 66. Pfizer Inc. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 67. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Addictions Therapeutics Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alkermes Plc
Amneal Pharmaceuticals Inc.
Indivior Plc
Johnson & Johnson Services Inc.
Mylan NV
Novartis AG
Novo Nordisk AS
Opiant Pharmaceuticals Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Frequently Asked Questions
Addictions Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Addictions Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Addictions Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Smallpox Treatment

Smallpox was an infectious disease caused by one of two virus variants, Variola major and Variola ... Read More